Nifty
Sensex
:
:
11199.00
37973.31
-51.55 (-0.46%)
-60.83 (-0.16%)

Pharmaceuticals & Drugs - Global

Rating :
76/99

BSE: 524404 | NSE: MARKSANS

48.60
21-Sep-2020
  • Open
  • High
  • Low
  • Previous Close
  •  51.80
  •  52.15
  •  48.60
  •  51.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1789553
  •  888.16
  •  57.10
  •  9.85

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,991.31
  • 13.55
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,916.47
  • 0.21%
  • 2.91

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 48.25%
  • 1.97%
  • 40.42%
  • FII
  • DII
  • Others
  • 3.28%
  • 0.00%
  • 6.08%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.05
  • 4.89
  • 7.51

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 7.74
  • 19.66

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 8.31
  • 52.59

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.98
  • 30.58
  • 16.64

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.37
  • 3.34
  • 2.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.26
  • 16.25
  • 11.21

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
331.15
245.03
35.15%
335.35
247.41
35.54%
287.65
248.37
15.82%
256.40
269.04
-4.70%
Expenses
261.13
212.61
22.82%
266.15
231.76
14.84%
240.36
212.18
13.28%
222.83
231.92
-3.92%
EBITDA
70.02
32.42
115.98%
69.20
15.65
342.17%
47.29
36.19
30.67%
33.57
37.12
-9.56%
EBIDTM
21.14%
13.23%
14.01%
6.33%
16.44%
14.57%
13.09%
13.80%
Other Income
0.18
2.18
-91.74%
0.03
9.73
-99.69%
0.03
0.16
-81.25%
7.88
-0.80
-
Interest
1.55
2.25
-31.11%
2.04
2.44
-16.39%
1.65
1.76
-6.25%
2.81
3.06
-8.17%
Depreciation
7.25
4.73
53.28%
9.63
6.27
53.59%
7.33
5.04
45.44%
4.98
5.54
-10.11%
PBT
61.40
27.61
122.38%
57.56
16.68
245.08%
38.34
29.55
29.75%
33.66
27.72
21.43%
Tax
12.04
5.13
134.70%
14.82
6.82
117.30%
8.78
4.42
98.64%
7.69
7.15
7.55%
PAT
49.36
22.48
119.57%
42.74
9.85
333.91%
29.56
25.13
17.63%
25.97
20.57
26.25%
PATM
14.91%
9.18%
7.11%
3.98%
10.28%
10.12%
10.13%
7.65%
EPS
1.21
0.55
120.00%
1.04
0.24
333.33%
0.72
0.61
18.03%
0.63
0.50
26.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,210.55
1,134.21
1,000.07
912.69
767.16
893.33
796.69
630.00
438.42
355.55
304.58
Net Sales Growth
19.87%
13.41%
9.57%
18.97%
-14.12%
12.13%
26.46%
43.70%
23.31%
16.73%
 
Cost Of Goods Sold
5,056.46
544.88
498.01
523.13
458.74
509.69
445.44
367.93
252.86
212.92
202.80
Gross Profit
-3,845.91
589.33
502.07
389.57
308.42
383.63
351.25
262.07
185.56
142.62
101.78
GP Margin
-317.70%
51.96%
50.20%
42.68%
40.20%
42.94%
44.09%
41.60%
42.32%
40.11%
33.42%
Total Expenditure
990.47
941.96
867.93
834.31
734.24
760.91
620.86
516.04
369.02
455.33
460.00
Power & Fuel Cost
-
14.38
14.34
11.83
13.27
12.58
9.72
7.80
6.12
4.89
4.99
% Of Sales
-
1.27%
1.43%
1.30%
1.73%
1.41%
1.22%
1.24%
1.40%
1.38%
1.64%
Employee Cost
-
168.42
159.07
147.75
149.70
122.42
72.61
66.44
55.91
45.70
36.26
% Of Sales
-
14.85%
15.91%
16.19%
19.51%
13.70%
9.11%
10.55%
12.75%
12.85%
11.90%
Manufacturing Exp.
-
87.39
77.14
59.90
47.34
50.44
37.59
30.11
9.85
8.76
8.75
% Of Sales
-
7.70%
7.71%
6.56%
6.17%
5.65%
4.72%
4.78%
2.25%
2.46%
2.87%
General & Admin Exp.
-
45.52
51.03
42.51
37.52
36.01
15.35
16.13
24.93
21.00
15.56
% Of Sales
-
4.01%
5.10%
4.66%
4.89%
4.03%
1.93%
2.56%
5.69%
5.91%
5.11%
Selling & Distn. Exp.
-
81.03
68.36
49.14
27.66
29.77
34.47
27.63
22.84
17.39
21.08
% Of Sales
-
7.14%
6.84%
5.38%
3.61%
3.33%
4.33%
4.39%
5.21%
4.89%
6.92%
Miscellaneous Exp.
-
0.34
0.00
0.05
0.00
0.00
5.67
0.00
-3.49
144.66
21.08
% Of Sales
-
0.03%
0%
0.01%
0%
0%
0.71%
0%
-0.80%
40.69%
56.00%
EBITDA
220.08
192.25
132.14
78.38
32.92
132.42
175.83
113.96
69.40
-99.78
-155.42
EBITDA Margin
18.18%
16.95%
13.21%
8.59%
4.29%
14.82%
22.07%
18.09%
15.83%
-28.06%
-51.03%
Other Income
8.12
0.33
4.63
8.47
18.85
12.72
12.23
7.28
4.40
2.05
3.62
Interest
8.05
8.75
9.66
10.22
6.78
10.16
16.05
19.13
14.60
53.58
43.67
Depreciation
29.19
26.66
22.80
26.84
30.09
28.13
16.13
15.69
15.65
23.70
19.98
PBT
190.96
157.17
104.31
49.80
14.90
106.85
155.88
86.41
43.55
-175.00
-215.44
Tax
43.33
36.42
23.87
14.00
3.56
24.11
43.92
12.79
-5.28
1.08
6.41
Tax Rate
22.69%
23.17%
22.88%
28.11%
23.89%
22.56%
28.18%
14.80%
-12.12%
-0.62%
-2.98%
PAT
147.63
117.02
76.46
32.94
8.83
78.51
109.39
71.90
45.89
-178.84
-223.25
PAT before Minority Interest
146.92
120.75
80.44
35.80
11.33
82.74
111.96
73.62
48.83
-176.08
-221.86
Minority Interest
-0.71
-3.73
-3.98
-2.86
-2.50
-4.23
-2.57
-1.72
-2.94
-2.76
-1.39
PAT Margin
12.20%
10.32%
7.65%
3.61%
1.15%
8.79%
13.73%
11.41%
10.47%
-50.30%
-73.30%
PAT Growth
89.20%
53.05%
132.12%
273.05%
-88.75%
-28.23%
52.14%
56.68%
-
-
 
EPS
3.61
2.86
1.87
0.80
0.22
1.92
2.67
1.76
1.12
-4.37
-5.45

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
636.01
542.48
470.86
433.43
454.32
379.76
142.18
86.48
-168.07
-62.61
Share Capital
40.93
40.93
40.93
40.93
53.43
53.43
52.03
52.03
50.28
50.28
Total Reserves
595.08
501.55
429.93
392.50
400.89
326.33
90.15
34.45
-219.51
-115.40
Non-Current Liabilities
27.40
17.14
15.64
16.07
-1.91
1.46
22.16
10.49
28.26
34.72
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
19.82
7.88
15.20
19.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.47
1.36
1.08
0.96
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
219.69
232.62
234.68
296.06
259.43
286.24
319.12
297.28
519.26
519.79
Trade Payables
104.50
106.07
77.83
161.78
118.98
107.02
83.18
56.06
58.62
55.11
Other Current Liabilities
55.62
20.90
10.08
0.71
0.68
39.88
96.58
108.73
336.39
341.76
Short Term Borrowings
18.84
99.91
117.41
109.71
87.89
82.19
105.54
113.79
113.92
115.98
Short Term Provisions
40.72
5.74
29.36
23.85
51.88
57.15
33.82
18.70
10.32
6.93
Total Liabilities
896.21
802.46
730.73
751.81
720.20
675.56
490.10
401.24
385.07
491.90
Net Block
302.72
269.73
279.38
266.98
269.65
165.90
145.65
156.12
165.35
278.59
Gross Block
565.39
506.26
495.35
456.49
429.47
297.78
261.70
256.88
250.51
340.13
Accumulated Depreciation
262.67
236.54
215.97
189.52
159.82
131.89
116.05
100.76
85.15
61.54
Non Current Assets
306.02
271.02
280.19
267.92
280.06
166.72
147.15
157.32
169.44
282.47
Capital Work in Progress
0.00
0.00
0.00
0.36
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
3.30
1.29
0.82
0.59
10.41
0.83
1.50
1.20
4.08
3.88
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
590.19
531.44
450.54
483.88
440.15
508.83
342.95
243.93
215.63
209.42
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
241.84
293.25
218.12
190.09
167.79
130.11
102.59
77.69
73.36
67.22
Sundry Debtors
243.35
176.60
176.91
247.58
217.29
183.45
169.61
131.31
112.77
98.86
Cash & Bank
93.73
33.54
39.88
25.16
35.30
185.27
46.95
15.88
22.39
30.92
Other Current Assets
11.26
28.06
15.63
0.09
19.76
10.01
23.80
19.04
7.11
12.42
Short Term Loans & Adv.
0.00
0.00
0.00
20.96
19.76
10.01
23.80
19.04
7.11
12.41
Net Current Assets
370.50
298.82
215.86
187.82
180.71
222.60
23.83
-53.36
-303.63
-310.37
Total Assets
896.21
802.46
730.73
751.80
720.21
675.55
490.10
401.25
385.07
491.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
209.94
27.40
50.09
14.06
30.80
154.51
64.84
38.56
-62.30
-65.04
PBT
157.17
104.31
49.80
14.90
106.85
109.40
71.91
45.88
-178.84
-223.24
Adjustment
42.04
31.88
43.99
26.58
39.63
24.26
19.57
27.85
124.15
112.61
Changes in Working Capital
35.73
-81.79
-36.23
-6.04
-88.14
20.27
-26.01
-35.18
-7.60
45.60
Cash after chg. in Working capital
234.94
54.40
57.56
35.44
58.34
153.94
65.47
38.56
-62.30
-65.04
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-25.00
-27.00
-7.46
-21.37
-27.54
-0.89
-0.27
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-59.53
-13.48
-38.81
-20.73
-123.01
-33.19
-4.49
-5.43
-3.25
24.68
Net Fixed Assets
-23.87
-23.07
-5.86
-11.49
-22.01
-32.23
-2.62
-4.85
90.35
146.70
Net Investments
0.00
0.00
-1.78
-2.85
-163.82
0.00
0.00
-44.11
44.11
10.00
Others
-35.66
9.59
-31.17
-6.39
62.82
-0.96
-1.87
43.53
-137.71
-132.02
Cash from Financing Activity
-90.15
-20.78
3.38
-3.47
-57.75
16.99
-29.28
-39.64
57.02
35.77
Net Cash Inflow / Outflow
60.27
-6.86
14.67
-10.14
-149.96
138.32
31.07
-6.51
-8.53
-4.58
Opening Cash & Equivalents
32.85
39.72
25.05
35.30
185.27
46.95
15.88
22.39
30.92
35.50
Closing Cash & Equivalent
93.12
32.85
39.72
25.16
35.30
185.27
46.95
15.88
22.39
30.92

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
15.54
13.25
11.50
10.59
10.79
8.97
3.34
1.89
-4.97
-2.14
ROA
14.22%
10.49%
4.83%
1.54%
11.86%
19.21%
16.52%
12.42%
-40.16%
-38.59%
ROE
20.49%
15.88%
7.92%
2.59%
20.45%
45.15%
73.02%
0.00%
0.00%
-645.23%
ROCE
25.57%
18.51%
10.60%
3.99%
23.16%
44.64%
38.30%
44.72%
-180.20%
-48.46%
Fixed Asset Turnover
2.12
2.00
1.92
1.73
2.46
2.85
2.43
1.73
1.20
0.74
Receivable days
67.57
64.51
84.88
110.59
81.87
80.88
87.17
101.60
108.63
115.71
Inventory Days
86.10
93.32
81.63
85.14
60.86
53.30
52.22
62.88
72.16
102.66
Payable days
43.87
38.48
55.10
65.56
54.58
56.06
48.85
59.34
68.51
70.79
Cash Conversion Cycle
109.80
119.35
111.40
130.17
88.15
78.13
90.54
105.14
112.28
147.58
Total Debt/Equity
0.03
0.18
0.25
0.25
0.19
0.23
1.12
1.88
-1.06
-2.87
Interest Cover
18.97
11.80
5.87
3.20
11.52
10.72
5.52
3.98
-2.27
-3.93

News Update:


  • Marksans Pharma - Quarterly Results
    4th Aug 2020, 11:28 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.